ARCHIVES

No Difference in Toxicity Between IMRT and PRT In Medicare Patients

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

In this 16-page issue: The Wall Street Journal editorial page leads campaign against efficacy standard.

August 5, 2005

Final Issue of ‘87

December 11, 1987

Risk of Relapse Continues After Five Years of Therapy

August 29, 2008

In Brief: Univ. of Texas Panel Selects Four finalists for M.D. Anderson Cancer Center Presidency

April 19, 1996

Symposium to Focus on New Approaches to Drug Resistance

May 11, 1990

Feinstein Slams Cancer Act Proposal, Calls White Paper Vague And Unrealistic.

October 19, 2001